pembrolizumabpembrolizumab-basedPD-1 inhibitorCCR8 antagonistGastric cancerFudan UniversityGCZhongshan Hospital
…nical outcomes but superior immunotherapeutic responsiveness to pembrolizumab in GC. Transcriptomic and phenotypic analyses revealed that tum…